Gene · 5029
Papers2,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulation of has_circ_0008389 promotes esophageal squamous cell carcinoma progression via miR-761 sponging and P2RY2 mRNA stabilization. | Int J Biol Macromol | 2025 | 40858175 | PubTator, text mining | PubMed |
| Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer. | Front Oncol | 2025 | 40746611 | PubTator, text mining | PubMed |
| RACK7 senses and fine-tunes enhancer activity. | iScience | 2025 | 40734674 | PubTator, text mining | PubMed |
| Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gαq-coupled receptors. | Cell Signal | 2025 | 40683327 | PubTator, text mining | PubMed |
| Purinergic receptors in atherosclerosis: implications for pathophysiology and therapeutic strategies. | J Physiol Biochem | 2025 | 40668534 | PubTator, text mining | PubMed |
| Anti-β2GPI/β2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides. | PLoS One | 2025 | 40403008 | PubTator, text mining | PubMed |
| Disruption of P2Y2 Signaling Promotes Breast Tumor Cell Dissemination by Reducing ATP-Dependent Calcium Elevation and Actin Localization to Cell Junctions. | Int J Mol Sci | 2025 | 40362524 | PubTator, text mining | PubMed |
| Structural insight into the self-activation and G-protein coupling of P2Y2 receptor. | Cell Discov | 2025 | 40360475 | PubTator, text mining | PubMed |
| Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer. | Cancer Cell Int | 2025 | 40264196 | PubTator, text mining | PubMed |
| Single-molecule localization microscopy as a tool to quantify di/oligomerization of receptor tyrosine kinases and G protein-coupled receptors. | Mol Pharmacol | 2025 | 40228395 | PubTator, text mining | PubMed |
| The Expression of F2RL1, P2RX2, P2RX3 and P2RY2 in the Esophagus of Patients with Gastroesophageal Reflux Disease and Their Relationship to Reflux Symptoms-A Pilot Study. | J Clin Med | 2025 | 40142692 | PubTator, text mining | PubMed |
| Ligand-Independent Spontaneous Activation of Purinergic P2Y6 Receptor Under Cell Culture Soft Substrate. | Cells | 2025 | 39937007 | PubTator, text mining | PubMed |
| G protein-coupled purinergic P2Y receptors in infectious diseases. | Pharmacol Ther | 2025 | 39814144 | PubTator, text mining | PubMed |
| P2Y2 Inhibition Modifies the Anabolic Response to Exercise in Adult Mice. | Aging Cell | 2025 | 39741419 | PubTator, text mining | PubMed |
| Glia-like taste cells mediate an intercellular mode of peripheral sweet adaptation. | Cell | 2025 | 39561773 | PubTator, text mining | PubMed |
| P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior. | Purinergic Signal | 2025 | 39425818 | PubTator, text mining | PubMed |
| Purinergic signaling in liver disease: calcium signaling and induction of inflammation. | Purinergic Signal | 2025 | 39320433 | PubTator, text mining | PubMed |
| Microglial purinergic signaling in Alzheimer's disease. | Purinergic Signal | 2025 | 38910192 | PubTator, text mining | PubMed |
| The functional role of P2 purinergic receptors in the progression of gastric cancer. | Purinergic Signal | 2025 | 38470513 | PubTator, text mining | PubMed |
| Deficiency of purinergic P2Y2 receptor impairs the recovery after renal ischemia-reperfusion injury and accelerates renal fibrosis and tubular senescence in mice. | Sci Rep | 2024 | 39738595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5029/papers?page=3